Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 million below the low end of the company’s prior guidance and ...

Eli Lilly (NYSE: LLY). Q4 2024 Earnings Call. Feb 06, 2025, 10:00 a.m. ET. Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here.

Summary. Eli Lilly and Company's Q4 and full-year earnings showcased impressive growth, driven by tirzepatide's success, leading to a 45% revenue increase in Q4 and 32% for the year.

Eli Lilly also posted a 90 bps improvement in gross margin to 83.2% in Q4. Higher revenues clubbed with margin expansion resulted in earnings of $5.32 per share, up over 2x from the $2.49 figure ...

Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B. The consensus revenue estimate stands at $13.95B.

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow morning. Here’s what to expect. Eli Lilly missed analysts’ revenue expectations by 6% last quarter ...

Eli Lilly revises Q4 revenue down on slower U.S. incretin market growth, eyes robust 2025 projections. ... Eli Lilly voiced hope for its long-term performance.

Reports Q4 revenue $13.53B, consensus $13.43B. “2024 was a highly successful year for Lilly,” said David Ricks, Lilly’s chair and CEO.

Eli Lilly (LLY) reports Q4 earnings Thursday. LLY stock up 8.22% YTD. Chart shows strong bullish momentum with potential for further gains. Analysts see 27% upside.